The Securities and Exchange Commission (SEC) has obtained a final judgment against stock promoter Carl Smith for misrepresentations he made to investors while raising funds for Nanobeak Biotech Inc.
The judgment was issued by the U.S. District Court for the Southern District of New York earlier in January.
According to the SEC’s complaint, filed on December 9, 2020, between at least December 2015 and December 2019, Nanobeak Biotech Inc. and its former CEO, Jeremy Barbera, solicited and sold Nanobeak securities using false and misleading statements. During this period, Nanobeak and Barbera, with the help of Smith, sold securities to at least 37 investors, raising a total of approximately $3.6 million.
Smith consented to the entry of a final judgment permanently enjoining him from violating Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The final judgment also ordered Smith to pay a civil money penalty of $100,000, and ordered disgorgement of $173,875, plus $23,470.59 in prejudgment interest.#sec#
风险提示：本文所述仅代表作者个人观点，不代表 Followme 的官方立场。Followme 不对内容的准确性、完整性或可靠性作出任何保证，对于基于该内容所采取的任何行为，不承担任何责任，除非另有书面明确说明。
加载失败()